✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹59 Cr.
P/E
28.23

Key Ratios

Market cap
Market cap
59.00 Cr
PE
PE
28.23
Prom Holding
Prom Holding
18.39 %
ROE (%)
ROE (%)
-26.34
ROCE (%)
ROCE (%)
-18.23
Div Yield (%)
Div Yield (%)
-
Sales
Sales
22.00 Cr
OPM (%)
OPM (%)
16.03 %
Debt to Equity
Debt to Equity
0.11
About
Aspira Pathlab & Diagnostics Limited is solely engaged in the business of running laboratories… Read more
Low
27
52W Range
High
107
  • Aspira Pathlab&Diagn
  • NG Industries
  • Aatmaj Healthcare

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Aspira Pathlab & Diagnostics Ltd. Business

Aspira Pathlab & Diagnostics Limited specializes in operating laboratories for a wide range of pathological investigations across multiple branches of healthcare.

Aspira Pathlab&Diagn major competitors are NG Industries, Aatmaj Healthcare, Constronics Infra, Medinova Diagnostic, Tejnaksh Healthcare, Transgene Biotek, Nidan Labs. & Health.
Market Cap of Aspira Pathlab&Diagn is ₹60 Crs.
While the median market cap of its peers are ₹39 Crs.

Aspira Pathlab&Diagn seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material